To further confirm the role of EZH2 in the glioblastoma metabolic switch in vivo, we used liquid chromatography-mass spectrometry (LC-MS) to examine the effect of EZH2 upregulation on levels of glycolytic metabolites. This evidence concerns the gene EZH2 and glioblastoma.